XRAY
DENTSPLY SIRONA Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +14.3% ·
share flow +23.8% ·
net new positions +12.5%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 112 | +3 | 126.37M | $1.34B | +9 | −7 |
| Q1 2026 | 113 | -4 | 123.81M | $1.43B | +7 | −12 |
| Q4 2025 | 118 | -2 | 133.13M | $1.52B | +1 | −2 |
| Q3 2025 | 21 | +1 | 79.76M | $1.01B | +2 | −2 |
| Q2 2025 | 18 | -2 | 86.79M | $1.38B | +1 | −3 |
| Q1 2025 | 17 | +1 | 42.87M | $640.10M | +3 | −2 |
| Q4 2024 | 16 | +2 | 36.02M | $684.31M | +2 | — |
| Q3 2024 | 13 | -1 | 22.34M | $604.46M | — | −1 |
| Q2 2024 | 14 | — | 20.51M | $510.86M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.55M | +18.7% | $238.19M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 6.76M | — | $129.43M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.61M | +1.8% | $68.58M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | AQR Capital Management ✦ | 2.89M | +245.1% | $54.39M | 0.1% | ▲ Add | 3 | SEC ↗ ×4 |
| 5 | Norges Bank ✦ (passive) | 2.41M | -1.4% | $45.73M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.93M | +185.9% | $36.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.69M | +35.5% | $32.00M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 997.41K | +861.9% | $18.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 829.95K | New | $15.75M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Gotham Asset Management ✦ | 770.81K | +8.5% | $14.63M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 731.66K | -39.6% | $13.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 383.35K | -37.1% | $7.28M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 225.52K | +24.4% | $4.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | ARK Investment Management ✦ | 137.32K | -0.2% | $2.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 96.13K | +45.8% | $1.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 9.43K | New | $178,971 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $15.75M | 0.0% |
| Point72 Asset Management | $178,971 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 378 holders, 212.22M shares, $2.44B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.